131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma

Table 3 Changes in blood cells and liver function before and 1 mo after treatment

Group	Test group	Control group	P value
Leukocytes	–1.25 ± 1.79	2.04 ± 11.51	0.0270
Platelets	–36.69 ± 49.62	12.74 ± 52.59	< 0.001
TB	1.7	0.95	0.860
Alb	–0.86 ± 6.89	–1.30 ± 5.36	0.6708
AST	5	7.5	0.631
ALT	–1	0	0.5137
HGB	–5.86 ± 16.42	–7.98 ± 20.26	0.515
KPS			< 0.001
Mass-associated pain			0.014

Total bilirubin (TB), Aspertate aminotransferase (AST), Glutamic-pyruvic transaminase (ALT), Karnofsky and pain (Wilcoxon rank sum test); others (t test). Alb: Albumin; HGB: Hemoglobin; KPS: Karnofsky performance score.